Teriparatide + Oral PTH (1-34)

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
25
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Drug Safety and Bioavailability

Conditions

Drug Safety and Bioavailability

Trial Timeline

Oct 1, 2013 โ†’ Oct 1, 2017

About Teriparatide + Oral PTH (1-34)

Teriparatide + Oral PTH (1-34) is a phase 1 stage product being developed by Entera Bio for Drug Safety and Bioavailability. The current trial status is completed. This product is registered under clinical trial identifier NCT02571140. Target conditions include Drug Safety and Bioavailability.

Hype Score Breakdown

Clinical
10
Activity
5
Company
2
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT02571140Phase 1Completed